Home Research Research themes Universal health coverage Protocols PR11050

PR11050

A phase 4 clinical trial in healthy infants to assess lot-to-lot consistency of Japanese encephalitis live attenuated SA 14-14-2 vaccine manufactured in a new good manufacturing practices facility and non-inferiority with respect to an earlier produc
Short Title Immunogenicity of SA 14-14-2 JE vaccine
Protocol No PR11050
Status Completed
Keywords IMMUNOGENICITY, SA 14-14-2 JE VACCINE
Center Communicable Diseases
MDG(s) this protocol relates to
HPNSDP(s) this protocol relates to
PI Name Md. Khalequzzaman
Collaborating Institutes (053) Institute of Epidemiology Disease Control and Research (IEDCR), Dhaka
(180) PATH, Seattle
(349) Chengdu Institute of Biological Products, China
Funding
Summary
‹ Search All Protocols Here